Sconty empire

Chinese volunteers in a clinical trial for the first COVID-19 vaccine developed by the country's military scientists received injections on Friday, marking a significant breakthrough that highlights China's strong research capabilities, according to experts.     The first batch of volunteers, all Wuhan permanent residents aged between 18 and 60, has been divided into three groups, each consisting of 36 members, the Science and Technology Daily reported on Saturday. They will be quarantined for 14 days and researchers will follow them for six months to monitor any adverse reactions.  The  product is a recombined vaccine jointly developed by Tianjin-based biotechnology company CanSino Biologics Inc and a research team headed by Chen Wei, an expert of biological hazard prevention and control from the PLA Academy of Military Medical Sciences and a major general of the Chinese military.  Since arriving in Wuhan in late January, Chen's team has undertaken pharmaceutical an